Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Stock That Needs Special Handling

Currently, there are 399.15M common shares owned by the public and among those 330.56M shares have been available to trade. The company’s stock has a 5-day price change of 10.61% and 9.77% over the past three months. RXRX shares are trading -32.09% year to date (YTD), with the 12-month market performance down to -13.61% lower. […]

Gains May Be On The Menu For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)

Currently, there are 399.15M common shares owned by the public and among those 310.64M shares have been available to trade. The company’s stock has a 5-day price change of -2.41% and -0.38% over the past three months. RXRX shares are trading -29.36% year to date (YTD), with the 12-month market performance down to -22.04% lower. […]

Gains May Be On The Menu For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)

Currently, there are 399.15M common shares owned by the public and among those 310.65M shares have been available to trade. The company’s stock has a 5-day price change of 0.00% and -15.75% over the past three months. RXRX shares are trading -46.38% year to date (YTD), with the 12-month market performance down to -25.59% lower. […]

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Is Getting Increasingly Hard To Ignore

Currently, there are 399.15M common shares owned by the public and among those 310.78M shares have been available to trade. The company’s stock has a 5-day price change of -10.38% and -22.52% over the past three months. RXRX shares are trading -27.22% year to date (YTD), with the 12-month market performance down to -42.66% lower. […]

Value Hunters: Look To Recursion Pharmaceuticals Inc (RXRX)

Currently, there are 399.15M common shares owned by the public and among those 310.78M shares have been available to trade. The company’s stock has a 5-day price change of 31.34% and -16.69% over the past three months. RXRX shares are trading -18.79% year to date (YTD), with the 12-month market performance down to -34.72% lower. […]

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today

Currently, there are 399.15M common shares owned by the public and among those 310.78M shares have been available to trade. The company’s stock has a 5-day price change of 0.84% and -44.34% over the past three months. RXRX shares are trading -38.17% year to date (YTD), with the 12-month market performance down to -53.50% lower. […]

Reviewing The Case For Recursion Pharmaceuticals Inc (RXRX) Going Higher

Currently, there are 399.15M common shares owned by the public and among those 310.78M shares have been available to trade. The company’s stock has a 5-day price change of -2.66% and -46.07% over the past three months. RXRX shares are trading -35.06% year to date (YTD), with the 12-month market performance down to -53.10% lower. […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.